Abstract
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.
MeSH terms
-
Algorithms
-
Blood Donors / statistics & numerical data*
-
Emigration and Immigration / statistics & numerical data
-
Female
-
Geography
-
HTLV-I Antibodies / blood
-
HTLV-I Infections / epidemiology*
-
HTLV-I Infections / immunology
-
HTLV-II Antibodies / blood
-
Humans
-
Israel / epidemiology
-
Male
-
Mass Screening / standards
-
Prevalence
Substances
-
HTLV-I Antibodies
-
HTLV-II Antibodies